In a move that could reshape how doctors approach both weight and heart health, the American College of Cardiology (ACC) ...

The American College of Cardiology has recommended that physicians embrace weight loss medications, such as semaglutide and tirzepatide, as first-line treatment options for patients at risk of ...

The doctor tells how Ozempic might be a new boon for treating heart health problems like strokes heart attack etc ...

In the context of new anti-obesity medications, the American College of Cardiology has issued a Scientific Statement updating ...

Early heart benefits before major weight changes One of the most intriguing aspects of semaglutide’s cardiovascular impact is the timing of these benefits. Recent analysis of extensive clinical ...

Semaglutide appears to reduce the risk of death, heart attack and stroke in adults with type 2 diabetes more effectively than ...

The list of benefits for Novo Nordisk's semaglutide keeps getting longer. Now, it seems the GLP-1 agonist could help patients with heart failure, adding to earlier studies showing it can treat ...

In this retrospective cohort study, treatment with semaglutide resulted in nominally lower incidence of the composite of ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7% on average.